Proficio Capital Partners LLC Takes $5.78 Million Position in ICU Medical, Inc. (NASDAQ:ICUI)

Proficio Capital Partners LLC purchased a new position in ICU Medical, Inc. (NASDAQ:ICUI) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 37,241 shares of the medical instruments supplier’s stock, valued at approximately $5,779,000. Proficio Capital Partners LLC owned 0.15% of ICU Medical as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the stock. FMR LLC lifted its position in shares of ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock worth $18,968,000 after purchasing an additional 100,345 shares during the period. State Street Corp lifted its holdings in ICU Medical by 9.3% in the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after buying an additional 77,506 shares during the period. Geode Capital Management LLC boosted its position in ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after acquiring an additional 48,106 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of ICU Medical by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock worth $54,868,000 after acquiring an additional 27,927 shares during the period. Finally, Principal Financial Group Inc. raised its position in shares of ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after acquiring an additional 25,031 shares in the last quarter. Institutional investors own 96.10% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. Finally, KeyCorp lifted their price target on shares of ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research report on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $199.67.

Insider Activity at ICU Medical

In related news, CEO Vivek Jain sold 1,373 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 6.70% of the stock is currently owned by insiders.

ICU Medical Trading Down 3.3 %

NASDAQ ICUI opened at $141.56 on Tuesday. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The stock’s fifty day moving average price is $160.16 and its 200-day moving average price is $166.21. The stock has a market cap of $3.47 billion, a P/E ratio of -30.98 and a beta of 0.63.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.